Loading…
SI-BONE, Inc. is projected to rise to $24.45 by 2027, a +39% move from its current price of $17.56. SIBN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/13/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $17.19 | $17.57 | $17.97 | +0.07% |
| Jul 15 | $17.04 | $17.59 | $18.15 | +0.14% |
| Jul 16 | $16.93 | $17.60 | $18.29 | +0.21% |
| Jul 17 | $16.84 | $17.61 | $18.41 | +0.29% |
| Jul 18 | $16.77 | $17.62 | $18.52 | +0.36% |
| Jul 19 | $16.70 | $17.64 | $18.62 | +0.43% |
| Jul 20 | $16.64 | $17.65 | $18.72 | +0.50% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $16.64 | $17.65 | $18.72 | +0.50% |
| Week 2 | $16.32 | $17.74 | $19.28 | +1.00% |
| Week 3 | $16.09 | $17.83 | $19.74 | +1.51% |
| Week 4 | $15.92 | $17.91 | $20.16 | +2.02% |
| Week 5 | $15.78 | $18.00 | $20.54 | +2.53% |
| Week 6 | $15.66 | $18.09 | $20.91 | +3.04% |
| Week 7 | $15.56 | $18.18 | $21.25 | +3.56% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
SI-BONE, Inc. is a medical device company that develops procedural solutions for compromised bone, grounded in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products.
The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers.
SI-BONE was incorporated in 2008 and is headquartered in Santa Clara, California.
SI-BONE, Inc. trades under the symbol SIBN and operates in the Healthcare sector as a medical device company focused on solutions for compromised bone. The current price is $17.33 with a market capitalization of $768.57M, and it holds a rank of 2726 in market size.
Near-term technicals show bullish momentum, with a 14-day RSI of 70, and key moving averages at SMA50 = $14.28 and SMA200 = $15.70. The stock sits above a support level of $13.87 and below a resistance level of $16.76, with a 30-day price range of $14.93 to $20.12.
The price outlook indicates meaningful upside over the multi-year horizon, with the forecast array showing rising averages from 2026 through 2050 and substantial long-run upside.
A major floor 33.9% below — a decisive break under it would weaken the trend.
The nearest floor, 21.0% below — buyers have tended to step in here.
Price is pressing into resistance (0.7% away) — a breakout level to watch.
A major ceiling 14.9% above — clearing it would confirm fresh momentum.
Key SIBN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SIBN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $17.37 | Buy | $17.31 | Buy |
| MA 10 | $17.13 | Buy | $17.05 | Buy |
| MA 20 | $16.41 | Buy | $16.51 | Buy |
| MA 50 | $14.97 | Buy | $15.52 | Buy |
| MA 100 | $14.43 | Buy | $15.25 | Buy |
| MA 200 | $15.79 | Buy | $15.50 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 64.23 | Neutral |
| Stoch RSI (14) | 33.63 | Neutral |
| CCI (20) | 100.70 | Buy |
| Williams %R (14) | -6.45 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | 10.09 | Buy |
| Bollinger %B (20,2) | 0.84 | Neutral |
| Stochastic %K (14) | 93.55 | Sell |
| TRIX (15) | 0.65 | Buy |
| Awesome (5,34) | 1.69 | Buy |
| Ultimate (7,14,28) | 69.66 | Neutral |
| Momentum (10) | 0.80 | Buy |
| Aroon Osc (25) | 84.00 | Buy |
| Hull MA (9) | 17.41 | Buy |
| ADX (14) | 25.14 | Buy |
| ATR (14) | 0.37 | Info |
Near-term sentiment is bullish. RSI14 is 70, and the stock price is testing resistance around $16.76 after trading within a 30-day range of $14.93 to $20.12.
The stock is above the SMA50 of $14.28 and the SMA200 of $15.70, with a support level at $13.87 and a resistance at $16.76. These factors, combined with the current price of $17.33, suggest continued near-term upside potential within the established range.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $11.61 | $17.56 | $25.10 | 0% | Neutral | |
| $19.80 | $24.45 | $31.73 | +39% | Bullish | |
| $22.61 | $28.56 | $38.22 | +63% | Bullish | |
| $24.24 | $31.18 | $42.76 | +78% | Bullish | |
| $25.99 | $33.97 | $47.57 | +93% | Bullish | |
| $26.76 | $35.50 | $50.61 | +102% | Bullish | |
| $28.83 | $38.77 | $56.18 | +121% | Bullish | |
| $34.25 | $46.65 | $68.59 | +166% | Bullish | |
| $39.02 | $53.79 | $80.18 | +206% | Bullish | |
| $42.48 | $59.24 | $89.42 | +237% | Bullish | |
| $56.80 | $83.41 | $132.79 | +375% | Bullish | |
| $105.27 | $168.65 | $290.37 | +860% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $11.61 | $17.56 | $21.16 | +0.00% |
| August 2026 | $15.82 | $18.57 | $22.32 | +5.78% |
| September 2026 | $15.87 | $18.74 | $22.73 | +0.89% |
| October 2026 | $15.91 | $18.89 | $23.09 | +0.78% |
| November 2026 | $16.52 | $19.69 | $24.23 | +4.24% |
| December 2026 | $16.95 | $20.27 | $25.10 | +2.97% |
Click any year to see its month-by-month SIBN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect SIBN to range from $11.61 to $25.10 through 2026. The $17.56 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The SIBN price prediction for 2027 points to an average of $24.45 (low $19.80, high $31.73) — a potential gain of +39% on today's $17.56. Momentum favours further upside here.
In 2028, SIBN is projected to trade between $22.61 and $38.22, averaging $28.56 — a potential gain of +63% from today's $17.56. That is up +17% on the projected 2027 average. Buyers look set to stay in control over this stretch.
SI-BONE, Inc.'s 2029 outlook centres on $31.18, within a $24.24 to $42.76 range. That is up +9% on the projected 2028 average. That marks a +78% change versus current levels. Momentum favours further upside here.
By 2030, SIBN could reach as high as $47.57, with a base case around $33.97 and support toward $25.99 — roughly +93% from $17.56. Buyers look set to stay in control over this stretch.
Expect SIBN to range from $26.76 to $50.61 through 2031. The $35.50 average target implies a +102% move from current prices. That is up +4% on the projected 2030 average. Momentum favours further upside here.
The SIBN price prediction for 2032 points to an average of $38.77 (low $28.83, high $56.18) — a potential gain of +121% on today's $17.56. Buyers look set to stay in control over this stretch.
In 2033, SIBN is projected to trade between $34.25 and $68.59, averaging $46.65 — a potential gain of +166% from today's $17.56. That is up +20% on the projected 2032 average. Momentum favours further upside here.
SI-BONE, Inc.'s 2034 outlook centres on $53.79, within a $39.02 to $80.18 range. That is up +15% on the projected 2033 average. That marks a +206% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, SIBN could reach as high as $89.42, with a base case around $59.24 and support toward $42.48 — roughly +237% from $17.56. Momentum favours further upside here.
Expect SIBN to range from $56.80 to $132.79 through 2040. The $83.41 average target implies a +375% move from current prices. That is up +41% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The SIBN price prediction for 2050 points to an average of $168.65 (low $105.27, high $290.37) — a potential gain of +860% on today's $17.56. Momentum favours further upside here.
Investing $1,000 in SIBN today (≈ 56.947608 SIBN) could be worth
$9,603.98
+$8,603.98 (+860%) by 2050 · US Dollar
Based on the average projected SIBN price of $168.65 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SIBNwould be worth at today's price.
$1,000 invested in SIBN on Jul 10, 2025 (≈ 53.248134 SIBN) would be worth
$935.04
-$64.96 (-6.5%) today · 0.94× · US Dollar
Based on a SIBN entry price of $18.78 vs. today's $17.56.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $17.11 | $1,026.3 | +2.6% |
| 1 month ago | $15.37 | $1,142.49 | +14.2% |
| 3 months ago | $12.84 | $1,367.6 | +36.8% |
| 6 months ago | $17.87 | $982.65 | -1.7% |
| 1 year ago | $18.78 | $935.04 | -6.5% |
| All time (5.0y) ago | $29.5 | $595.25 | -40.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SIBN forecast.
Our base-case forecast reaches $35.00 around 2031.
Implied market cap at $35.00: $1.55B
The multi-year forecast shows sustained upside with rising averages and strong long-run potential. For 2027 the avg is $24.13 with ROI 39.2% and bullish sentiment; for 2028 the avg is $28.78 with ROI 66.1%. 2029’s avg is $30.60 (ROI 76.6%), and 2030’s avg is $33.32 (ROI 92.3%), all with bullish sentiment.
Beyond 2030, the trajectory continues higher with 2031 avg $35.43 (ROI 104.5%), 2032 avg $37.81 (ROI 118.2%), and 2033 avg $46.31 (ROI 167.2%). The 2034 and 2035 forecasts show further gains to averages of $53.64 (ROI 209.5%) and $57.34 (ROI 230.9%), respectively, with bullish sentiment.
In 2040, the average forecast climbs to $83.16 (ROI 379.8%), and by 2050 the average is $162.79 (ROI 839.4%), with a max across years up to $281.85. These figures illustrate a long-run upside path, but they are estimates, not guarantees, and come with uncertainty and risks inherent in forward projections.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $33.32 with a max of $46.82 and a min of $25.42; ROI is 92.3%.
The 2026 forecast is Neutral with an average price of $17.33 and ROI 0; from 2027 onward, the outlook is Bullish with rising averages and positive ROIs (e.g., 2027 avg $24.13, ROI 39.2%).
Yes. The max forecast price for 2031 is $50.70 and for 2032 is $54.99.
Current price: $17.33. Market cap: $768.57M.
Bullish sentiment with RSI14 at 70. The 30-day range is $14.93 to $20.12, SMA50 is $14.28, SMA200 is $15.70, support is $13.87, and resistance is $16.76.
SI-BONE, Inc. Community Discussion
0Share your SI-BONE, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.